NCT05992337 - New Biomarkers in the Prediction of Chemotherapy-induced Cardiotoxicity. | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

November 30, 2024

Study Completion Date

January 31, 2025

Conditions

CardiotoxicityChemotherapy EffectChemotherapy Induced Systolic Dysfunction

Interventions

DIAGNOSTIC_TEST

Blood sampling

Blood sample collection for mRNA determination

DIAGNOSTIC_TEST

Echocardiography

Echocardiography for detection of ventricular dysfunction

DIAGNOSTIC_TEST

Cardio MRI

MRI for early detection of myocardial impairment caused by chemotherapy

DIAGNOSTIC_TEST

24-hours monitoring of ECG

Diagnostic test for detection of arrhythmias as a consequence of cardiotoxicity

DIAGNOSTIC_TEST

24 hours monitoring of BP

Diagnostic test for detection of hypertension as a consequence of cardiotoxicity

Trial Locations (2)

RECRUITING

Cardiology Prague Ltd, Prague

RECRUITING

Oncology Center Medicon, Prague